• Medientyp: E-Book; Sonderdruck
  • Titel: Immunological markers as predictors of developing steroid-induced diabetes mellitus in pemphigus vulgaris patients: An observational study
  • Beteiligte: Dănescu, Ana Sorina [VerfasserIn]; Baldea, Ioana [VerfasserIn]; Leucuta, Daniel Corneliu [VerfasserIn]; Lupan, Iulia [VerfasserIn]; Samaşca, Gabriel [VerfasserIn]; Sitaru, Cassian [VerfasserIn]; Chiorean, Roxana [VerfasserIn]; Baican, Adrian [VerfasserIn]
  • Erschienen: Baltimore, Md.: Ovid Technologies (Wolters Kluwer Health), 2018
  • Erschienen in: Medicine ; 97, 17 (2018), e0463
  • Umfang: 1 Online-Ressource (5 Seiten); Diagramme
  • Sprache: Englisch
  • DOI: 10.1097/md.0000000000010463
  • ISSN: 1536-5964
  • Identifikator:
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: Abstract: The aim of this study was to evaluate the clinical importance of autoantibodies in pemphigus vulgaris patients who developed steroid-induced diabetes mellitus (SID) because of the glucocorticoid therapy of pemphigus.<br><br>A total of 137 patients with pemphigus vulgaris were studied. Patients with SID and pemphigus were compared with those that had only pemphigus. The variables recorded were: age at diagnosis, sex, body mass index, presence of diabetes mellitus (DM), cumulative cortisone dose, treatment duration, value of anti-desmoglein 1 and 3, and anti-glutamic acid decarboxylase autoantibodies.<br><br>A total of 31 patients (22.62%) that developed steroid-induced DM were identified. Anti-glutamic acid decarboxylase autoantibodies were positive in 20.75% of patients with pemphigus vulgaris and in 25.75% of patients with pemphigus vulgaris and SID.<br><br>The overall anti-glutamic acid decarboxylase autoantibodies prevalence in pemphigus patients was high, and the risk of developing DM in patients with pemphigus remains a serious problem, being associated with increased risk of mortality
  • Zugangsstatus: Freier Zugang